Your browser doesn't support javascript.
loading
TFF-1 Functions to Suppress Multiple Phenotypes Associated with Lung Cancer Progression.
Minegishi, Kentaro; Dobashi, Yoh; Tsubochi, Hiroyoshi; Hagiwara, Koichi; Ishibashi, Yuko; Nomura, Sachiyo; Nakamura, Ritsuko; Ohmoto, Yasukazu; Endo, Shunsuke.
Afiliação
  • Minegishi K; Department of Thoracic Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
  • Dobashi Y; Department of Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
  • Tsubochi H; Department of Pathology, School of Medicine, International University of Health and Welfare, Tochigi, Japan.
  • Hagiwara K; Department of Thoracic Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
  • Ishibashi Y; Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University, Tochigi, Japan.
  • Nomura S; Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Nakamura R; Division of Breast Surgery, Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Ohmoto Y; Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Endo S; Department of Molecular and Cellular Pathology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Onco Targets Ther ; 14: 4761-4777, 2021.
Article em En | MEDLINE | ID: mdl-34531663
INTRODUCTION: Trefoil Factor (TFF) is a member of a protein family comprised of three isoforms, of which TFF-1 exhibits antithetical functions; promotion or suppression of cell proliferation, survival and invasion, depending on the cancer type. However, the pathobiological function of TFF-1 in lung carcinoma has been still unclear. METHODS: We examined the expression and secretion of TFF-1 using cultured human lung carcinoma cells by immunoblotting, immunofluorescence, enzyme-linked immunosorbent assay and quantitative real-time PCR analyses. The effects of TFF-1 on various phenotypes were analyzed in two cell lines, including those transfected with cDNA encoding TFF-1. Cell proliferation and death were examined by hemocytometer cell counting and by colorimetric viability/cytotoxicity assay. Cell cycle profile, migration and invasion were also examined by flow cytometry, wound healing assay and Matrigel Transwell assay, respectively. The effect of TFF-1 overexpression was confirmed by additional transfection of TFF-1-specific siRNA. RESULTS: Endogenous TFF-1 protein expression and secretion into the media were observed exclusively in adenocarcinoma-derived cell lines. Forced overexpression of TFF-1 drove cell cycle transition, while the proliferation decreased by 19% to 25% due to increased cell death. This cell death was predominantly caused by apoptosis, as assessed by the activation of caspase 3/7. Cell migration was also suppressed by 71% to 82% in TFF-1-transfected cells. The suppressive effect of TFF-1 on proliferation and migration was restored by transfection of TFF-1 siRNA. Moreover, invasion was also suppressed to 77% to 83% in TFF-1-transfected cells. CONCLUSION: These findings reveal that TFF-1 functions as a suppressor of cancer proliferation by induction of apoptosis, cell migration and invasion and thus may provide a synergistic target for potential treatment strategies for human lung carcinoma.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Onco Targets Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Onco Targets Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão